LEX-WK-010FKH8Mcrawled 2020-12-02 06:21Z
FDA Accepts Review of Samsung Bioepis and Biogen’s Ranibizumab Biosimilar
Grant B. Lukas · Biosimilars Law Bulletin · Published December 2, 2020
Work details
- author
- Grant B. Lukas
- firm or organization
- Rothwell Figg
- publication
- Biosimilars Law Bulletin
- practice area
- Health Care and Life Sciences
- published
- 2020-12-02
Citation
Grant B. Lukas, FDA Accepts Review of Samsung Bioepis and Biogen’s Ranibizumab Biosimilar, Biosimilars Law Bulletin (December 2, 2020) [The Library at LexBlog, LEX-WK-010FKH8M, lexpid.org/010FKH8M]